small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (313)
  • Capabilities (70)
  • Experience (42)
  • Insights & News (1,611)
  • Other Results (54)

Professionals 313 results

Kelly A. Librera
Kelly A. Librera
Partner
  • New York
Email
+1 212-294-4622
vCard

Partner

  • New York
George Mastoris
George Mastoris
Partner
  • New York
Email
+1 212-294-4623
vCard

Partner

  • New York
T. Reed Stephens
T. Reed Stephens
Partner
  • Washington, DC
Email
+1 202-282-5795
vCard

Partner

  • Washington, DC
View All Professionals

Capabilities 70 results

Industry

Insurance

Insurance plays an essential role in risk mitigation for financial services companies. As risks evolve, questions often arise concerning the scope of insurance coverage and the interpretation and application of policy provisions. Winston’s insurance lawyers provide companies with best-in-class advice, corporate and transactional counsel, and, if need be, litigation defense in high-stakes coverage disputes and class actions. We have achieved excellent outcomes for our clients in matters involving a wide variety of insurance policies and claims, including cybersecurity, travel, long-term care, and annuities, among others. Moreover, we have experience in emerging issues and industries, such as blockchain technology and artificial intelligence, both of which present insurers with a unique and complicated set of risks and opportunities....Read more

Practice Area

Insurance Litigation

For decades, Winston has represented a broad array of clients in the insurance industry, including some of the world’s largest and best-known insurers. Our prowess in and understanding of the insurance industry encompasses not only its products, practices, and services, but also the increasing challenges posed by a world increasingly characterized by a fast-evolving technological landscape as well as financial, political, and environmental instability. Accordingly, Winston’s lawyers are among the most sought-after in the industry—not only by companies currently facing high-stakes litigations and investigations, but by those looking to take preventive action now in order to mitigate and manage their risk in the future....Read more

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Experience 42 results

Experience

|

June 12, 2025

Winston Serves as Lead Counsel to GCP Capital Partners in New Continuation Vehicle

Winston & Strawn served as legal counsel to GCP Capital Partners (GCP) in connection with the formation and closing of a single-asset continuation vehicle involving ALKEME Insurance. Led by the PE and Funds Group practices, the team advised GCP throughout the transaction which included substantial newly committed capital to fund portfolio company ALKEME’s continued growth (the single asset). The fund raise was backed by a syndicate of institutional investors where Apollo S3 served as the lead investor. The deal signals a growing trend: the strategic use of continuation vehicles to extend sponsors’ ownership in high-performing portfolio companies. This deal also reflects a broader narrative in middle-market private equity: firms that started small are now scaling rapidly, and they’re turning to sophisticated liquidity solutions to fuel that growth....Read more

Experience

|

April 23, 2025

Voyager Acquisition Corp. and VERAXA Biotech Announce Business Combination

Winston & Strawn represented Voyager Acquisition Corp. in its announced business combination agreement with VERAXA Biotech AG, a biopharmaceutical company developing next-generation antibody-based cancer therapies. The combination will result in VERAXA becoming a publicly traded company on Nasdaq under the ticker symbol “VERX”, with a pre-money equity valuation of $1.3 billion and up to $253 million in cash held in trust by Voyager. The transaction is expected to close in the fourth quarter of 2025, subject to regulatory and shareholder approvals....Read more

Experience

|

October 3, 2024

Drilling Tools International Corp. in its Acquisition of European Drilling Projects

Winston & Strawn represented Houston-based Drilling Tools International Corp. (NASDAQ: DTI) (DTI), a global oilfield services company that designs, engineers, manufactures, and provides a differentiated, rental-focused offering of tools for use in onshore and offshore drilling operations, as well as other cutting-edge solutions across the well life cycle, in its acquisition of Amsterdam-based European Drilling Projects (EDP), a global provider of next-generation stabilizers, specialty reamers, and wellbore optimization technology for the drilling industry. The integration of EDP's expertise aligns seamlessly with DTI's international growth strategy and commitment to technological differentiation. The acquisition of EDP not only enhances DTI's competitive edge but also reinforces its position as a leader in providing innovative drilling solutions to the global oil and gas industry....Read more
View All Experience

Insights & News 1,611 results

Global Trade & Foreign Policy Insights

|

October 31, 2025

|

4 Min Read

EU Publishes 19th Sanctions Packages Against Russia

As Russia’s military aggression against Ukraine continues, the European Union (EU) has maintained its commitment to increasing economic and legal pressure on Russia. In 2025, the EU adopted its 16th, 17th, 18th, and now 19th sanctions packages, each introducing new measures and expanding existing restrictions. 

Recognitions

|

October 30, 2025

|

Less Than 1 Min Read

Winston & Strawn Recognized in 2026 Benchmark Litigation

Winston & Strawn has been recognized in the 2026 edition of Benchmark Litigation, which covers the litigation and disputes market in North America. The firm is recognized for its excellence in litigation in the following categories:...Read more

Life at Winston

|

October 21, 2025

|

2 Min Read

Winston For Good Heroes: Grine Lahreche Blends Local Advocacy with International Influence

Grine’s unique mix of philanthropic work connects local and international communities through compassion and a common purpose. Whether he is uniting countries around pivotal issues, mentoring children in underserved neighborhoods, or stepping into a boxing ring for charity, Grine leads by example.

View All Insights & News

Other Results 54 results

Site Content

Attorney Work-Life Integration

Site Content

What Is Healthcare Privacy Law?

Today, healthcare privacy law is driven by the 1996 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. This federal privacy rule establishes protections for specific patient health information. Healthcare plans, clearinghouses, and providers are subject to the law....Read more

Site Content

Who Are Institutional Investors?

Institutional investors are large non-individual shareholders, including hedge funds, pension funds, mutual funds, endowment funds, and insurance companies....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising